Compare GPOR & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GPOR | MMSI |
|---|---|---|
| Founded | 1997 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 4.0B |
| IPO Year | 1998 | 1996 |
| Metric | GPOR | MMSI |
|---|---|---|
| Price | $191.17 | $62.13 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 8 |
| Target Price | ★ $233.33 | $98.88 |
| AVG Volume (30 Days) | 262.4K | ★ 524.4K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 245.92 | 4.93 |
| EPS | ★ 21.48 | 0.68 |
| Revenue | $1,422,583,000.00 | ★ $1,515,906,000.00 |
| Revenue This Year | $18.35 | $8.85 |
| Revenue Next Year | $6.04 | $5.88 |
| P/E Ratio | ★ $8.99 | $31.68 |
| Revenue Growth | ★ 48.47 | 11.75 |
| 52 Week Low | $160.95 | $63.78 |
| 52 Week High | $225.78 | $99.26 |
| Indicator | GPOR | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 41.32 | 33.30 |
| Support Level | $174.88 | N/A |
| Resistance Level | $191.86 | $71.68 |
| Average True Range (ATR) | 5.72 | 2.42 |
| MACD | 0.12 | -0.40 |
| Stochastic Oscillator | 49.10 | 7.36 |
Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition, and production of natural gas, crude oil, and natural gas liquids, with assets located in the Appalachia and Anadarko basins in the United States. The principal properties of the company are located in eastern Ohio, targeting the Utica and Marcellus, and in central Oklahoma, targeting the SCOOP Woodford and Springer formations.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.